Cargando…

Eculizumab Dosing in Infants

Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome (aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children and 5 infants) and one prospective trial (22 patients and 5 infants). This case report highlights the need for more preci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobrzynski, M., Wile, B., Huang, S. S., Filler, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830814/ https://www.ncbi.nlm.nih.gov/pubmed/29515306 http://dx.doi.org/10.4103/ijn.IJN_310_16

Ejemplares similares

Successful Treatment of Multiple Angiomyolipomas with Sirolimus in a Child
por: Pabedinskas, K., et al.
Publicado: (2017)

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule
por: Gatault, Philippe, et al.
Publicado: (2015)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

Eculizumab: COVID-19: case report
Publicado: (2021)

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report
por: Füreder, Wolfgang, et al.
Publicado: (2020)

The use of eculizumab in gemcitabine induced thrombotic microangiopathy
por: Krishnappa, Vinod, et al.
Publicado: (2018)

The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
por: Gabr, Jihad Ben, et al.
Publicado: (2020)

Eculizumab/tocilizumab: Various toxicities: case report
Publicado: (2020)

Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis
por: Sharma, Ruby, et al.
Publicado: (2015)

Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature
por: Thomson, Nick, et al.
Publicado: (2016)

Eculizumab as a promising treatment in thymoma-associated myasthenia gravis
por: Vélez-Santamaría, Valentina, et al.
Publicado: (2020)

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
por: Ohanian, Maro, et al.
Publicado: (2011)

Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
por: Raufi, Alexander G., et al.
Publicado: (2016)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
por: Umscheid, Jacob H., et al.
Publicado: (2021)

Eculizumab‐related drug reaction in a patient with neuromyelitis optica
por: Sharma, Rishi, et al.
Publicado: (2023)

Seizures Related to Hypomagnesemia: A Case Series and Review of the Literature
por: Chen, Becky Biqi, et al.
Publicado: (2016)

Placental disposition of eculizumab, C5 and C5‐eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
por: Eliesen, Gaby A.M., et al.
Publicado: (2020)

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
por: Wijnsma, Kioa Lente, et al.
Publicado: (2019)

Eculizumab treatment for renal failure in a pediatric patient with COVID-19
por: Mahajan, Ruchi, et al.
Publicado: (2020)

Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding
por: Fujita, Yoko, et al.
Publicado: (2020)

Anticoagulants/eculizumab/elasomeran: Various toxicities and lack of efficacy: case report
Publicado: (2022)

Eculizumab: Lack of efficacy following off-label use: case report
Publicado: (2021)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report
por: Van den Eeckhaut, Lisa, et al.
Publicado: (2022)

A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
por: Chidharla, Anusha, et al.
Publicado: (2021)

Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced
por: Sethi, S. K., et al.
Publicado: (2017)

Clinical Relapses of Atypical HUS on Eculizumab: Clinical Gap for Monitoring and Individualised Therapy
por: Teoh, Chia Wei, et al.
Publicado: (2018)

Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation
por: Brodsky, Andrés, et al.
Publicado: (2012)

Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab
por: Andries, Gabriela, et al.
Publicado: (2017)

Gemcitabine and carfilzomib induced thrombotic microangiopathy: eculizumab as a life‐saving treatment
por: Gosain, Rahul, et al.
Publicado: (2017)

Severe Infection of Pseudomonas aeruginosa during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria
por: Kawakami, Toru, et al.
Publicado: (2017)

Eculizumab for pediatric dense deposit disease: A case report and literature review
por: Kasahara, Katsuaki, et al.
Publicado: (2020)

COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy
por: Gill, Jasmeet, et al.
Publicado: (2021)

The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
por: Bjørkto, Magnus Holter, et al.
Publicado: (2021)

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab
por: Weidmayer, Sara L., et al.
Publicado: (2023)

Atypical Haemolytic Uraemic Syndrome Associated with Clostridium difficile Infection Successfully Treated with Eculizumab
por: Inglis, Joshua M., et al.
Publicado: (2018)

Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report
por: Alexopoulou, Alexandra, et al.
Publicado: (2019)

Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab
por: Uriarte, Maite Hurtado, et al.
Publicado: (2018)

Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
por: Hausberg, Martin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iql5r37l5k4nqco3iop5l9dl3m